Voyageur announces PEA with NPV of $344 million and 137% IRR for Frances Creek Barium Project in BC

Voyageur Pharmaceuticals is focused on the development of barite and iodine Active Pharmaceutical Ingredients and high-performance cost-effective imaging contrast agents for the medical radiology marketplace.

Keywords: Video news alert, world news, latest news, cryptocurrency, bitcoin, investmentpitch media, CSE, TSXV, TSE, stock market news, investmentpitch